Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Cash & Equivalents	176.5	99.81	1.57	4.72
Cash & Short-Term Investments	176.5	99.81	1.57	4.72
Cash Growth	76.84%	6269.24%	-66.80%	-
Prepaid Expenses	2.25	1.04	0.21	-
Total Current Assets	178.74	100.84	1.78	4.72
Property, Plant & Equipment	0.09	-	-	-
Long-Term Deferred Charges	-	-	3.49	-
Other Long-Term Assets	0.7	-	-	-
Total Assets	179.53	100.84	5.26	4.72
Accounts Payable	0.73	2.75	2.01	0.01
Accrued Expenses	9.28	7.55	0.82	-
Short-Term Debt	-	-	7.76	-
Other Current Liabilities	9.5	10	4.23	0.03
Total Current Liabilities	19.51	20.3	14.82	0.04
Other Long-Term Liabilities	-	0.99	-	-
Total Liabilities	19.51	21.29	14.82	0.04
Common Stock	0.01	0	-	-
Additional Paid-In Capital	302.71	162.82	-	-
Retained Earnings	-155.9	-103.49	-32.06	-7.82
Total Common Equity	146.82	59.33	-32.06	-7.82
Minority Interest	13.2	20.22	10	-
Shareholders' Equity	160.02	79.55	-9.56	4.68
Total Liabilities & Equity	179.53	100.84	5.26	4.72
Total Debt	-	-	7.76	-
Net Cash (Debt)	176.5	99.81	-6.19	4.72
Net Cash Growth	76.84%	-	-	-
Net Cash Per Share	2.35	3.02	-27.13	-
Filing Date Shares Outstanding	68.37	43.59	43.09	17.25
Total Common Shares Outstanding	65.3	43.59	0.38	17.25
Working Capital	159.23	80.54	-13.04	4.68
Book Value Per Share	2.25	1.36	-83.59	-0.45
Tangible Book Value	146.82	59.33	-32.06	-7.82
Tangible Book Value Per Share	2.25	1.36	-83.59	-0.45

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q